commentary
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
commentary
May 22, 2024, 09:36 |
Blog
Marco Donia: Does participation in Cancer Clinical Trials improve survival outcomes on its own?
Marco Donia, made the following post on LinkedIn: "Does participation in Cancer Clinical Trials improve survival…
Apr 6, 2024, 14:56 |
Insight
Kimryn Rathmell: My Cancer Discovery commentary for a new perspective on the National Cancer Plan
Kimryn Rathmell, Director of the National Cancer Institute, recently shared on X: "Ready for AACR24?…
Jan 8, 2024, 09:57 |
Insight
Vivek Subbiah: Dr. Timil Patel and colleagues from the FDA Oncology call upon the drug development community to find ways to make clinical trials simpler
Vivek Subbiah shared on X: "Since clinical trials in oncology that are submitted for regulatory…
Nov 14, 2023, 03:56 |
Insight
Guru P. Sonpavde: Honored to write this commentary...
Guru P. Sonpavde, GU Oncology Director at Advent Health Cancer Institute, shared on X/Twitter: "Nivolumab…
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube